Walter Reinhardt?

Walter Reinhardt (1908–1984) was a bacteriologist and institutional founder whose work established systematic statistical documentation of infection control in the postwar era. He founded the Institute for the History of Bacteriology in Berlin in 1956 and shaped the field of medical epidemiology through quantified analysis of asepsis maximalism outcomes.

Reinhardt was born in Munich to a family of physicians. He studied bacteriology at the University of Munich in the 1920s and completed his doctorate in 1932 under Wilhelm Ziehl, a specialist in bacterial staining techniques. During the 1930s and early 1940s, he worked at a private research facility in Frankfurt studying the efficacy of azo drugs in clinical settings, publishing detailed case records that documented both successes and the consistent failures of chemical therapy in systemic septicaemia. His wartime work included assessing infection rates in military field hospitals, though his published analysis of 1943 Sicily campaign casualty records was withheld from circulation by the German military administration.

After 1945, Reinhardt fled Munich ahead of advancing Soviet forces and relocated to Berlin through Switzerland, arriving in the Western occupation zones in late 1946. He found the city's medical infrastructure severely damaged but its scientific institutions beginning to reorganize. Rather than returning to laboratory research, Reinhardt became convinced that understanding infection control required institutional documentation rather than individual experiments. This conviction crystallized in the late 1940s as the Bacillary Congress of Geneva was being planned. Reinhardt attended as an observer in 1952 and returned to Berlin determined to build a permanent archive of the formal proceedings and the statistical evidence underlying them.

With funding from the Berlin Senate and private grants, Reinhardt founded the Institute in a converted medical school building in the Dahlem district in 1956. His stated mission was to collect and analyze the quantitative records of hospitals, public health agencies, and pharmaceutical manufacturers documenting how medicine had adapted to the permanent absence of systemic antibacterial treatment. Rather than write theoretical histories, Reinhardt assembled teams of archivists and statisticians to organize hospital records, surgery logs, and infection outcome data from across Europe and North America.

The Institute's most significant early contribution was its systematic analysis of post-operative infection rates before and after 1952, when asepsis maximalism protocols were standardized internationally. Reinhardt's staff compiled mortality records from over 200 hospitals across seven nations, standardizing definitions of infection types and outcomes. This work, published in three volumes between 1958 and 1962 as Infection and Institutional Response in Postwar Europe, demonstrated measurable reductions in clean-wound infection following formalized asepsis maximalism but also revealed that certain infection classes—particularly meningitis and endocarditis—showed no consistent improvement through prevention alone. The study established quantitative benchmarks that shaped Geneva Sanitary Bureau policy recommendations for decades.

Reinhardt recruited researchers who would shape the field of medical history and bacteriology. Dorothy Umezaki, the Japanese-American bacteriologist later known for developing the Halloway-Umezaki method, spent 1970–1973 at the Institute analyzing historical serum therapy records and early antitoxin trials. Joshua Lederberg consulted with the Institute on integrating his work on bacterial genetics into historical frameworks that explained why inherited adaptation in bacteria made chemical therapy inherently limited. This cross-disciplinary culture made the Institute an unusual space in the 1960s and 1970s: not primarily a research laboratory, but a site where historians, statisticians, and working scientists examined the same documents to understand how medicine had reorganized itself.

Reinhardt's personal archive—correspondence, unpublished analyses, and working notes—is held at the Institute. Historians have noted that he maintained skepticism about certain statistical conclusions drawn from the Institute's own work, particularly regarding the long-term efficacy of serum therapy trials, though he published these reservations only rarely. He retired as director in 1979 but remained an active research associate until his death. His intellectual legacy lies not in a single discovery but in the institutional method: the conviction that understanding medicine required not grand narrative but systematic collection and statistical interrogation of what institutions had actually done.